The diseases share some surprising similarities, and experts now think studying COVID-19 patients' brains could lead to better treatments for both conditions.
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer s. Doctors have refused to prescribe it, given the lack of data and evidence behind it.